Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Date: Monday, May 5, 2025 Time: 2:30 p.m. Eastern Time Location: Metro Toronto Convention Centre, Toronto Webcast: https://event.summitcast.com/view/hG2KhRan38C8o5wZiWyxNK/6hRWPTiDpf8iZLFakhbeJ6 ...

Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...

Terpenes, derived from the Cannabis sativa plant, may be the basis of a medication for fibromyalgia and post-surgical pain ...

With a watery consistency, this formula is tops at providing weightless hydration that won't leave behind an unflattering ...

Patients are growing increasingly interested in medical marijuana. As this interest grows, dermatologists must be prepared to ...

Perspective Therapeutics, Inc.’s CATX share price has dipped by 5.02%, which has investors questioning if this is right time ...

estrogen receptor alpha, estrogen receptor beta, glucocorticoid receptor, peroxisome proliferator-activated receptor gamma, and thyroid hormone receptor alpha. For each nuclear receptor, we selected a ...

Both function by binding to protein receptors on cells. The four primary receptors — alpha-1, alpha-2, beta-1, and beta-2 — are located in different body areas. The impact of norepinephrine and ...

Institute of Biology and Experimental Medicine, National Council for Scientific and Technical Research, Buenos Aires, Argentina. Research Center of Biomedical Biotechnology, Environmental and ...